Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00573833 · ClinicalTrials.gov registry record · NA

Internal Radiation Therapy in Treating Patients With Prostate Cancer

A NA study of Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT00573833: Completed NA study of Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00573833 is a NA study of Prostate Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 23 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00573833, a NA study of Prostate Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. PURPOSE: This clinical trial is studying the side effects and how well internal radiation therapy works in treating patients with prostate cancer.

Conditions Studied

Interventions

  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • RADIATION brachytherapy

Study Locations (1)

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2007-11
Est. Completion 2014-09
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00573833

The ClinicalTrials.gov registry entry for NCT00573833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.

NCT00573833 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00573833 about?

NCT00573833 is a clinical study titled "Internal Radiation Therapy in Treating Patients With Prostate Cancer". RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. PURPOSE: This clinical trial is studying the side effects and how well internal radiation therapy works in treating patients with prostate cancer.

What is the current status of trial NCT00573833?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2007-11. Estimated completion is 2014-09.

What conditions does trial NCT00573833 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00573833?

The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), brachytherapy (RADIATION).

Who is sponsoring clinical trial NCT00573833?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00573833 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.